Ali Behbahani
Direttore/Membro del Consiglio presso Tidal Therapeutics, Inc.
Profilo
Ali Behbahani currently works at Tidal Therapeutics, Inc., as Director.
Posizioni attive di Ali Behbahani
| Società | Posizione | Inizio |
|---|---|---|
Tidal Therapeutics, Inc.
 Tidal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Tidal Therapeutics, Inc. is a preclinical biotech company based in Quincy, MA. Tidal Therapeutics, Inc. focuses on developing nanoparticles that deliver to reprogram immune cells inside the body, with applications in oncology and immune diseases. Ulrik B. Nielsen has been the CEO of the company since 2018. Tidal Therapeutics was acquired by Sanofi on April 09, 2021 for $470 million. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Tidal Therapeutics, Inc.
Tidal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Tidal Therapeutics, Inc. is a preclinical biotech company based in Quincy, MA. Tidal Therapeutics, Inc. focuses on developing nanoparticles that deliver to reprogram immune cells inside the body, with applications in oncology and immune diseases. Ulrik B. Nielsen has been the CEO of the company since 2018. Tidal Therapeutics was acquired by Sanofi on April 09, 2021 for $470 million. | Commercial Services |
- Borsa valori
- Insiders
- Ali Behbahani
